AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 12, 2024. Key executives, including President and COO Robert A. Michael, CFO Scott T. Reents, CCO Jeffrey R. Stewart, and Chief Medical Officer Dr. Roopal Thakkar, will present at 9:00 a.m. Central time. Investors can access a live audio webcast through AbbVie's Investor Relations website, with an archived version available later in the day.

Positive

• AbbVie's participation in a major healthcare conference highlights its active engagement in industry discussions.
• Top executives' involvement suggests the potential for significant strategic updates and insights.
• The live audio webcast increases accessibility for investors and stakeholders, promoting transparency.

Negative

• No new financial data or clinical results were disclosed in the press release.
• The announcement lacks specific details on what will be presented, which may limit immediate investor excitement.

NORTH CHICAGO, Ill., June 3, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 9:00 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference-302161924.html

SOURCE AbbVie

FAQ

When will AbbVie present at the Goldman Sachs 45th Annual Global Healthcare Conference?

AbbVie will present on June 12, 2024.

Which AbbVie executives will present at the conference?

President and COO Robert A. Michael, CFO Scott T. Reents, CCO Jeffrey R. Stewart, and Chief Medical Officer Dr. Roopal Thakkar will present.

How can investors access AbbVie's presentation at the conference?

Investors can access a live audio webcast through AbbVie's Investor Relations website, with an archived version available later in the day.

What time will AbbVie present at the Goldman Sachs healthcare conference?

AbbVie will present at 9:00 a.m. Central time.